Below are the most recent publications written about "Plasmodium falciparum" by people in Profiles.
-
Carey-Ewend K, Marten A, Muller J, Peter EE, Odas M, Dominick MC, Muller M, Chhetri S, Amagai K, Rutha I, Kisandu F, Beka L, Kharabora O, Popkin-Hall ZR, Bailey J, Edwards JK, Gower EW, Juliano JJ, Ngasala BE, Lin JT. Seasonal Variation and Interspecies Dynamics Among Plasmodium falciparum and ovale Species in Bagamoyo, Tanzania. J Infect Dis. 2026 Feb 18; 233(2):391-400.
-
Connelly SV, Muller JG, Ali M, Ngasala BE, Hassan W, Mohamed B, Thwai KL, Sadler JM, Marglous J, Fola AA, Zacharia A, Shija SJ, Mohammed S, C Msolo D, Said H, Peter EE, Odas M, Rutha IJ, Nwange M, Naire K, Ruybal-Pes?ntez S, Verity R, Crudale R, Goel V, Choloi BB, Bj?rkman A, Bailey JA, Lin JT, Juliano JJ. Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023. J Infect Dis. 2026 Feb 18; 233(2):e491-e495.
-
Zeleke AJ, Fola AA, Tollefson GA, Niar? K, Leonetti A, Taropawala O, Marglous J, Crudale R, Brhane BG, Assefa A, Kiyuka P, Parr JB, Hailu A, Tegegne MA, Bailey JA. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLoS Pathog. 2025 Dec; 21(12):e1013771.
-
Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.
-
White SJ, Tchuenkam VPK, Mbouh M, Gaither C, Bouopda-Tuedom AG, Kiam BC, Popkin-Hall ZR, Sadler JM, Carey-Ewend K, Hand E, Ngum MN, Ngomsi YN, Bailey JA, Kaunda DB, Mafo LK, Lemogo GN, Dinka CL, Nsani CA, Noubom M, Goel V, Ibrahima I, Onguene JC, Lin FC, Lin JT, Nsango SE, Dinglasan RR, Juliano JJ, Ali IM. Epidemiology of ovale, vivax and falciparum malaria in the highlands of Cameroon: An integrated community survey of human infection and vector abundance. PLoS Negl Trop Dis. 2025 Oct; 19(10):e0013549.
-
Watson OJ, Tran TN, Zupko RJ, Symons T, Thomson R, Visser T, Rumisha S, Dzianach PA, Hathaway N, Kim I, Juliano JJ, Bailey JA, Slater H, Okell L, Gething P, Ghani A, Boni MF, Parr JB, Cunningham J. Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions. Nat Med. 2025 Oct; 31(10):3372-3379.
-
Gaither C, Morgan C, Kirby R, Karema C, Gashema P, Zuromski J, White SJ, Topazian HM, Giesbrecht D, Thwai K, Young NW, Goel V, Boyter K, Munyaneza T, Muvunyi CM, Butera JD, Bailey JA, Mazarati JB, Juliano JJ. Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health Survey. PLoS One. 2025; 20(9):e0330480.
-
Okitwi M, Orena S, Tumwebaze PK, Katairo T, Taremwa Y, Byaruhanga O, Tukwasibwe S, Nsobya SL, Legac J, Bailey JA, Cooper RA, Conrad MD, Rosenthal PJ. Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024. Nat Commun. 2025 Aug 09; 16(1):7353.
-
Rosado J, Fola AA, Cojean S, Sarrasin V, Copp?e R, Bailly J, Zaffaroulah R, Bouzayene A, Cic?ron L, Houz? L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houz? S. Assessment of ex vivo antimalarial drug efficacy in African Plasmodium falciparum parasite isolates, 2016-2023: a genotype-phenotype association study. EBioMedicine. 2025 Aug; 118:105835.
-
Katairo T, Asua V, Nsengimaana B, Tukwasibwe S, Semakuba FD, Wiringilimaana I, Kagurusi BA, Mwubaha C, Nakasaanya J, Garg S, Kiyaga S, Mbabazi M, Kabbale KD, Ayitewala A, Nsobya SL, Kamya MR, Ssewanyana I, Bailey JA, Aranda-D?az A, Rosenthal PJ, Greenhouse B, Briggs J, Conrad MD. Performance of molecular inversion probe DR23K and Paragon MAD4HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistance. Malar J. 2025 Jun 12; 24(1):188.